Dry powder inhaler is referred to a device that helps to deliver medication to the lungs in the form of dry powder. Dry powder inhaler is widely used to treat respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and others. Dry powder inhaler is very easy and convenient way to deliver medicine into human being.
- Advertising -
“Dry Powder Inhaler Market: Global Historical Growth (2012-2016) & Future Outlook (2017-2024) Demand Analysis & Opportunity Evaluation”
The global dry powder inhaler market is segmented into application such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, cardiovascular disease, diabetes and others. Additionally, asthma captured the largest segment in 2016 and it is expected to garner at a remarkable CAGR during the forecast period.
Further, the growth of this segment is attributed to increasing number of population affected with asthma. Likely, rising demand for advanced healthcare device to cure various respiratory related diseases is projected to foster the growth of dry powder inhaler market.
- Advertising -
Moreover, continuous advancement in healthcare products is also believed to spur the growth dry powder inhaler market.
Global dry powder inhaler market is expected to register a noteworthy CAGR over the forecast period. Moreover, the global dry powder inhaler market is anticipated to reach at exponential sales globally by 2024.
The market is expected to expand on the back of favorable government initiatives to develop the healthcare infrastructure.
The single dose segment by type is predicted to attain at a significant CAGR during the forecast period. In term of geography, North America region accounted for the largest market of dry powder inhaler in terms of revenue.
In addition to this U.S. is anticipated to be the major contributor in the growth of dry powder inhaler market owing to presence of major key players of dry powder inhaler such as Mannkind Corporation. Apart from this, Asia-Pacific region is projected to be most lucrative market of dry powder inhaler due to emerging economies such as India and China.
Moreover, presence of highest number of aged population in Japan coupled with growing healthcare infrastructure is also believed to foster the growth of dry powder inhaler market in this region.
Rapid urbanization coupled with swelled disposable income has encouraged the population to adopt advance and innovative healthcare products which is expected to fuel the growth of dry powder inhaler market. Furthermore, increasing GDP figures of developing and developed nation such as U.S., China and others and rising research and development activities by major key players are also believed to flourish the growth of dry powder inhaler market.
Rising geriatric population
Increasing geriatric population across the globe and rising exposure to smoke & chemicals are envisioned to augment the demand for dry powder inhaler. Moreover, increasing adoption of unhealthy lifestyle and increasing number of respiratory diseases such as chronic obstructive pulmonary disease (COPD) is boosting the demand for dry powder inhaler market.
On the contrary, lack of awareness regarding dry powder inhaler is projected to hamper the growth of dry powder inhaler market by the end of 2024.
The report titled “Dry Powder Inhaler Market: Global Historical Growth (2012-2016) & Future Outlook (2017-2024) Demand Analysis & Opportunity Evaluation” delivers detailed overview of the global dry powder inhaler market in terms of market segmentation by type, by application, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
This report also provides the existing competitive scenario of some of the key players of the global dry powder inhaler market which includes company profiling of Mannkind Corporation, Cipla Inc., Hovione FarmaCiencia SA, GlaxoSmithKline Plc., Meda Pharmaceuticals Inc., 3M Company, AstraZeneca Plc., Vectura Group Plc., Teicos Pharma Ltd and Teva Pharmaceutical Industries. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments.
On the whole, the report depicts detailed overview of the global dry powder inhaler market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Category: Market Research Publishers and RetailersCompany profile: Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wis ...
For more information: